Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
344
NCT01394055
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2011
Completion: Dec 31, 2012
NCT01571297
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
Phase: Phase 2
Start: Apr 30, 2012
Completion: Sep 30, 2013
NCT01642550
Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa
Start: Nov 30, 2012
Completion: Mar 31, 2015
NCT01781104
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
Start: Mar 31, 2013
Completion: Oct 31, 2014
NCT01955616
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
Start: Sep 30, 2013
Completion: Sep 30, 2015
NCT02137642
Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation
Start: Aug 31, 2014
Completion: Nov 30, 2014
NCT02466711
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
Start: Jun 30, 2015